Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Ad icon
Iptv
musicking
Updated:
Yesterday at 9:52 AM
Ad icon
ZTE MF283U 4G Unlocked Router (Used)
ayanthamaxi
Updated:
Jul 19, 2026
ලංකාවේ හොඳම උපකාරක පන්ති සහ ගුරුවරුන් එකම තැනකින් - TopTuition.lk
dulithapathum
Updated:
Jul 18, 2026
Colombo
RidhMathraa ’26 🎶✨
Tmadhusanka
Updated:
Jul 15, 2026
Ad icon
Colombo
PXN V10 Pro Direct Drive Racing Wheel (Under Warranty)
Abdur Rahman
Updated:
Jul 15, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
General
ElaKiri Talk!
Johnson & Johnson said its one-dose vaccine was 66% effective in a global trial
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="Deleted" data-source="post: 26090852" data-attributes="member: 559066"><p><strong>The Covid-19 vaccine developed by Janssen is 66% effective, the Belgian company has announced.</strong></p><p></p><p>But nobody needed hospital treatment or died from coronavirus after the vaccine took effect in the international trial.</p><p>Crucially, it looked at giving just one dose of the vaccine, which makes it significantly easier to roll out than those requiring two.</p><p></p><p>Although there are also signs it is less effective against the new variant that is spreading in South Africa.</p><p></p><p>The news comes shortly after Novavax announced <a href="https://www.bbc.co.uk/news/uk-55850352" target="_blank">their jab was 89% effective overall</a> and 60% in South Africa. Both new vaccines will need to be reviewed by regulators before they can be used.</p><p>Janssen, a pharmaceutical company owned by Johnson & Johnson, is also investigating whether giving two doses will give either stronger or longer-lasting protection.</p><p></p><p>The fact it works as a single-dose and can be kept in a standard fridge, while others need super-cold storage, means the vaccine could have a significant role around the world.</p><p></p><p>"A one-shot vaccine is considered by the World Health Organization to be the best option in pandemic settings," said Dr Paul Stoffels, the chief scientific officer at Johnson & Johnson.</p><p></p><p><img src="https://ichef.bbci.co.uk/news/800/cpsprodpb/03DD/production/_116398900_vaccines_09-nc.png" alt="" class="fr-fic fr-dii fr-draggable " style="" /></p><p></p><p>BBC</p></blockquote><p></p>
[QUOTE="Deleted, post: 26090852, member: 559066"] [B]The Covid-19 vaccine developed by Janssen is 66% effective, the Belgian company has announced.[/B] But nobody needed hospital treatment or died from coronavirus after the vaccine took effect in the international trial. Crucially, it looked at giving just one dose of the vaccine, which makes it significantly easier to roll out than those requiring two. Although there are also signs it is less effective against the new variant that is spreading in South Africa. The news comes shortly after Novavax announced [URL='https://www.bbc.co.uk/news/uk-55850352']their jab was 89% effective overall[/URL] and 60% in South Africa. Both new vaccines will need to be reviewed by regulators before they can be used. Janssen, a pharmaceutical company owned by Johnson & Johnson, is also investigating whether giving two doses will give either stronger or longer-lasting protection. The fact it works as a single-dose and can be kept in a standard fridge, while others need super-cold storage, means the vaccine could have a significant role around the world. "A one-shot vaccine is considered by the World Health Organization to be the best option in pandemic settings," said Dr Paul Stoffels, the chief scientific officer at Johnson & Johnson. [IMG]https://ichef.bbci.co.uk/news/800/cpsprodpb/03DD/production/_116398900_vaccines_09-nc.png[/IMG] BBC [/QUOTE]
Insert quotes…
Verification
Winadiyakata thappara keeyak tibeda?
Post reply
Top
Bottom